Comparison of Recovery Profile After TIVA Between Remimazolam With Flumazenil and Propofol in patients undergoing short-duration gynecologic surgery under general anesthesia
- Conditions
- Neoplasms
- Registration Number
- KCT0008314
- Lead Sponsor
- Korea University Ansan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 86
1) Patients undergoing ambulatory gynecological surgery under general anesthesia or gynecological surgery that is expected to take less than 30 minutes
2) Adult female patients aged 20-60 years
3) American Society of Anesthesiology Classification 1,2 patients
4) Patients who gave informed consent to the study
1) American Society of Anesthesiologists (ASA) physical classification III or higher
2) BMI > 40kg/m2
3) If you are allergic to remimazolam or profopol or to other drugs used in the study (benzodiazepines, propofol, remifentanil, fentanyl citrate, rocuronium bromide, sugammadex, flumazenil)
4) If the operation is expected to last more than 2 hours
5) If antidepressants, psychiatric medications, rifampicin, succinycholine, neostigmine, flumazenil, or cyclosporin are administered before surgery
6) If you have a serious illness that can affect your systemic condition, including cancer or cardiopulmonary, liver, or kidney disease.
7) Patients with galactose intolerance or lactase deficiency or glucose-galactose malabsorption
8) Patients with medical or psychological diseases that may affect treatment response, patients with life-span disorders
9) Pregnant women
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time from when the anesthetic is stopped until the patient opens their eyes
- Secondary Outcome Measures
Name Time Method Time from discontinuation of anesthesia to extubation, time from completion of surgery to discharge